PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
XLYS LOW TRY Analog powder
090401000BBMVA0
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
XLYS TRY Glutaridon powder
0913221C0BBAAAA
XLYS TRY powder 80g protein equivalent per 100g Powder 80g protein equivalent per 100g (0913221) Nutrition and Blood No data available
XMET Analog powder
090401000BBEBA0
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
XMTVI Analog powder
090401000BBECA0
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
Xofluza 40mg tablets
0503040D0BBAAAA
Xofluza Baloxavir marboxil Infections No data available
Xofluza 80mg tablets
0503040D0BBABAB
Xofluza Baloxavir marboxil Infections No data available
Xolair 150mg inj vials
0304020X0BBAAAA
Xolair Omalizumab Respiratory System No data available
Xolair 150mg/1ml solution for injection pre-filled pens
0304020X0BBADAD
Xolair Omalizumab Respiratory System No data available
Xolair 150mg/1ml solution for injection pre-filled syringes
0304020X0BBACAC
Xolair Omalizumab Respiratory System No data available
Xolair 300mg/2ml solution for injection pre-filled pens
0304020X0BBAFAF
Xolair Omalizumab Respiratory System No data available
Xolair 300mg/2ml solution for injection pre-filled syringes
0304020X0BBAGAG
Xolair Omalizumab Respiratory System No data available
Xolair 75mg/0.5ml solution for injection pre-filled pens
0304020X0BBAEAE
Xolair Omalizumab Respiratory System No data available
Xolair 75mg/0.5ml solution for injection pre-filled syringes
0304020X0BBABAB
Xolair Omalizumab Respiratory System No data available
Xospata 40mg tablets
0801030AGBBAAAA
Xospata Gilteritinib Malignant Disease and Immunosuppression No data available
XP Analog LCP powder
090401000BBIWA0
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
XP Analog powder
090401000BBEDA0
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
XP Maxamaid Concentrate powder
090401000BBCDA0
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
XPHEN TYR Analog powder
090401000BBEEA0
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
XPTM Analog powder
090401000BBICA0
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
XPTM Tyrosidon powder
090401000BBENA0
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
Xtandi 40mg capsules
0803042U0BBAAAA
Xtandi Enzalutamide Malignant Disease and Immunosuppression No data available
Xtandi 40mg tablets
0803042U0BBABAB
Xtandi Enzalutamide Malignant Disease and Immunosuppression No data available
Xtrasorb Foam dressing (adhesive) 15.5cm x 15.5cm square
20030600532
Xtrasorb Foam dressing (adhesive) 15.5cm x 15.5cm square Wound Management & Other Dressings Dressings No data available
Xtrasorb HCS Adhesive dressing 8cm x 8cm square
20031700155
Xtrasorb HCS Adhesive dressing 8cm x 8cm square Wound Management & Other Dressings Dressings No data available
Xtrasorb HCS dressing 20cm x 20cm square
20031700154
Xtrasorb HCS dressing 20cm x 20cm square Wound Management & Other Dressings Dressings No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.